<DOC>
	<DOCNO>NCT01067404</DOCNO>
	<brief_summary>Each winter , virus belong two kind influenza A ( `` A/H1N1 '' &amp; `` A/H3N2 '' ) two kind influenza B ( `` B/Yamagata '' &amp; `` B/Victoria '' ) cause illness . The yearly influenza vaccine design protect kind influenza A one kind influenza B . The vaccine change year year , meaning may include one kind B virus one year kind another year . But influenza hard predict , sometimes kind B virus choose vaccine may match kind cause illness . The National Advisory Committee Immunization recommend infant toddler receive influenza vaccine protect high rate hospitalization . Infants/toddlers receive influenza vaccine first time must get two dos ( prime plus boost ) good antibody response . If ever receive single dose influenza vaccine , recommend receive one dose year afterwards . But n't know well previous dos one kind influenza B set stage good antibody response single dose kind influenza B . This study try answer question group infants/toddlers last year receive two dos one kind B virus ( `` Yamagata '' ) , part another study . This year , give single dose influenza vaccine contain kind B virus ( `` Victoria '' ) see much antibody make kind . About half child receive high amount influenza vaccine previous year 's study , also compare antibody level basis . Since influenza B illness especially child , understand best protect infants/toddlers kinds influenza B important . This study help u know need design new vaccine include kind influenza A , also kinds influenza B .</brief_summary>
	<brief_title>TIV Infant/Toddler Response Evaluation ( TITRE ) - Follow-up &amp; Focus Influenza B</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Child previously participate TITRE I study ; Child healthy ( stable chronic condition acceptable ) establish health assessment interview verbal historydirected health examination ; Child receive 2009 pandemic H1N1 influenza vaccine ; Child available complete relevant procedure study period ; Parent legal guardian available reach phone study period ; Parent/guardian provide write informed consent ; And , parent/guardian fluent English/French . Child already receive 200910 seasonal ( TIV ) influenza vaccine ; Child receive immune globulin blood product within prior six week ; Child receive injected oral steroid within prior six week ; Child enrol clinical trial drug , vaccine medical device study period ; Or , child recently acquire health condition , opinion investigator , would interfere evaluation pose health risk child .</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Influenza vaccine</keyword>
	<keyword>Infant</keyword>
	<keyword>Dose-Response relationship , immunologic</keyword>
</DOC>